Cocrystal Pharma to Participate at the H.C. Wainwright Global Investment Conference

Rhea-AI Summary

Cocrystal Pharma (Nasdaq: COCP) announced its participation in the upcoming H.C. Wainwright 27th Annual Global Investment Conference. CFO and co-CEO James Martin will deliver a company overview presentation on September 9, 2025 at 12:00 p.m. Eastern time.

The event will be held at the Lotte New York Palace Hotel, offering both in-person and virtual attendance options. Martin will be available for one-on-one meetings with institutional investors and industry professionals throughout the conference. The presentation materials are accessible on the company's website.

News Market Reaction – COCP

-2.64%

2 alerts

-2.64% Session close to close

-2.1% Trough Tracked

$14.98M Market Cap

0.3x Rel. Volume

In the Sep 3 session, COCP declined 2.64%, reflecting a moderate negative market reaction. Argus tracked a trough of -2.1% from its starting point during tracking. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOTHELL, Wash., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a company overview at the H.C. Wainwright 27^th Annual Global Investment Conference on Tuesday, September 9, 2025 at 12:00 p.m. Eastern time.

Mr. Martin will be available throughout the conference for in-person and virtual one-on-one meetings. Institutional investors and industry professionals can register to attend the conference virtually or in-person at the Lotte New York Palace Hotel. The Cocrystal Pharma presentation is posted to the Company website here.

About Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company that addresses significant unmet needs by developing innovative antiviral treatments for challenging diseases including influenza, viral gastroenteritis, COVID, and hepatitis. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs.

Contact:
Alliance Advisors IR
Jody Cain
310-691-7100
jcain@allianceadvisors.com

# # #

FAQ

When is Cocrystal Pharma (COCP) presenting at the H.C. Wainwright Conference?

Cocrystal Pharma will present on Tuesday, September 9, 2025 at 12:00 p.m. Eastern time.

Who will be presenting for Cocrystal Pharma at the H.C. Wainwright Conference?

James Martin, who serves as both CFO and co-CEO of Cocrystal Pharma, will present the company overview.

Where can I access Cocrystal Pharma's (COCP) H.C. Wainwright presentation?

The presentation is available on Cocrystal Pharma's company website.

How can investors attend Cocrystal Pharma's presentation at the H.C. Wainwright Conference?

Institutional investors and industry professionals can attend either virtually or in-person at the Lotte New York Palace Hotel by registering for the conference.